Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Advances in Therapy
Published in: Advances in Therapy 6/2002

01-11-2002

The lipidosterolic extract ofSerenoa repens in the treatment of benign prostatic hyperplasia: A comparison of two dosage regimens

Authors: X. Giannakopoulos, M.D., Ph.D., D. Baltogiannis, M.D., Ph.D., D. Giannakis, M.D., Ph.D., A. Tasos, M.D., N. Sofikitis, M.D., Ph.D., D.M.Sci., K. Charalabopoulos, M.D., Ph.D., A. Evangelou, M.D., Ph.D.

Published in: Advances in Therapy | Issue 6/2002

Login to get access
Metadata
Title
The lipidosterolic extract ofSerenoa repens in the treatment of benign prostatic hyperplasia: A comparison of two dosage regimens
Authors
X. Giannakopoulos, M.D., Ph.D.
D. Baltogiannis, M.D., Ph.D.
D. Giannakis, M.D., Ph.D.
A. Tasos, M.D.
N. Sofikitis, M.D., Ph.D., D.M.Sci.
K. Charalabopoulos, M.D., Ph.D.
A. Evangelou, M.D., Ph.D.
Publication date
01-11-2002
Publisher
Springer Healthcare Communications
Published in
Advances in Therapy / Issue 6/2002
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/BF02853174

Other articles of this Issue 6/2002

Advances in Therapy 6/2002 Go to the issue

OriginalPaper

Intravenous and local intra-arterial tissue-plasminogen activator in a rabbit model of acute thromboembolic stroke: Angiographic comparison

OriginalPaper

Moclobemide in the treatment of hot flashes in postmenopausal women

OriginalPaper

Long-term clinical and biologic effects of the lipidosterolic extract ofSerenoa repens in patients with symptomatic benign prostatic hyperplasia

OriginalPaper

Do variable age-related secondary factors affect ventricular geometry in hypertrophic cardiomyopathy?

OriginalPaper

Efficacy of bimatoprost in glaucoma and ocular hypertension unresponsive to latanoprost
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits